✓ Doğrulanmış
Güven puanı 98/100
Dr. Hariharan Kuhan
· London
👤 6 yıllık deneyim
6,915+
Patients seen
6
Years in practice
9
Publications
1
Languages spoken
Hakkında
Dr Hariharan Kuhan is the Co-Founder and Medical Director of Lucio Health, where he leads the development of personalised, data-driven approaches to cancer and metabolic health. His clinical background spans mainstream oncology, early-phase trials, and academic research, with a strong focus on integrating metabolic medicine into modern cancer care.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Hariharan Kuhan
Eğitim ve öğretim
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency
-
2020–2021 Fellowship · Subspecialty training
Kariyer ve atamalar
-
2020-09–2021-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of
Mesleki sorumluluk sigortası:
Generali Healthcare · 4,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 1,527 |
| Annual physical exam | 99395 | 2,361 |
| Vaccination administration | 90471 | 417 |
| Minor procedure (skin) | 17110 | 2,758 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 dk | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 dk | in_clinic | 540.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 18 · i10: 9
-
Outcomes of in adults — a multi-centre cohort
DOI: 10.1289/euroclin.2025.0 · PMID: 33124820 · alıntılayan 39
-
European registry analysis of outcomes
DOI: 10.6802/euroclin.2024.1 · PMID: 30650891 · alıntılayan 157
Davetli konuşmalar
- Practical updates in European Annual Congress () · Vienna · 2024 · invited
- Single-centre experience in National Society Meeting · London · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2021 yılından beri
- national college of family doctors — Member · 2021 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2021 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to
- Awareness When should you see a ?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · hariharan.kuhan@euroclinics.example
- Kabul edilen uluslararası sigortalar
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Konum
1 etiketHasta yorumları
26 doğrulanmış yorum5.00
★★★★★
26 yorum
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.